The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro and Perimenopause — What UK Adults Should Know
Perimenopause brings hormonal changes that often lead to weight gain, particularly around the midsection. Many UK women find weight management more challenging during this life stage due to fluctuating oestrogen levels, slower metabolism, and increased appetite. Mounjaro (tirzepatide) is a prescription-only weight management injection that may help, though it's not specifically licensed for perimenopause. This guide explains how Mounjaro works, NHS eligibility criteria, and what the evidence shows about weight management during midlife transitions.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
NHS Eligibility and Mounjaro Access in the UK
Mounjaro is available in the UK through NHS specialist tier 3 weight management services or via private prescription. You'll need to meet NHS eligibility criteria: a BMI of 30 kg/m² or above, or 25–29.9 with weight-related health conditions (such as type 2 diabetes, high blood pressure, or sleep apnoea). Lower BMI thresholds (27.5+) apply if you're of South Asian, Chinese, Black African, or Black Caribbean heritage.
During perimenopause, weight-related conditions often develop or worsen — many women experience new-onset high blood pressure or worsening metabolic markers, which may make them eligible for NHS specialist treatment. Access routes differ: the NHS route involves referral to a tier 3 service (waiting lists vary by region), while private prescription is available through GPhC-registered pharmacies following an online clinical assessment. MHRA monitoring status (Black Triangle ▼) means Mounjaro is under enhanced safety surveillance in the UK, reflecting the need for careful medical oversight when prescribing, particularly during hormonal transitions.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
How Mounjaro May Help During Perimenopause
Mounjaro works as a dual GIP and GLP-1 receptor agonist — a mechanism different from older GLP-1 injections like Wegovy (semaglutide). This dual action may be particularly relevant during perimenopause, as it addresses appetite regulation through two hormone pathways simultaneously. Clinical trials showed average weight loss of 15–21% body weight alongside dietary changes and increased physical activity. Individual results vary significantly.
Perimenopause hormonal shifts can intensify cravings and reduce fullness signals. By supporting appetite regulation and helping you feel fuller after smaller meals, Mounjaro may assist in maintaining weight during a period when natural metabolic slowdown often leads to gains. However, medication works best alongside lifestyle changes — sustainable weight management through perimenopause requires attention to diet quality, physical activity (particularly strength training), stress management, and sleep. Always discuss how Mounjaro might interact with any HRT or other medications you're taking with your prescriber.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can I take Mounjaro while on HRT during perimenopause?
This is a clinical decision your prescriber must assess. Mounjaro doesn't directly interact with hormone replacement therapy, but your prescriber will need to review all medications together. Oral contraceptives are specifically affected by Mounjaro (absorption may reduce), so if you're on HRT, discuss this with your GP or prescriber before starting.
Does Mounjaro help with perimenopause weight gain specifically?
Mounjaro isn't licensed specifically for perimenopause, but may help with weight management during this stage if you meet eligibility criteria. The underlying hormone-driven appetite changes during perimenopause mean weight management medications can be helpful — discuss your individual situation with your GP or the tier 3 specialist service.
What's the difference between Mounjaro and Wegovy for perimenopause weight?
Both are prescription-only injections, but Mounjaro uses dual GIP+GLP-1 action (higher average weight loss in trials: 15–21%), while Wegovy (semaglutide) uses GLP-1 alone (average 15%). Mounjaro dosing also allows higher maximum doses (15 mg vs 2.4 mg). Your prescriber will recommend based on your medical history and eligibility.
How long does it take to see weight loss results on Mounjaro?
Most people see noticeable changes within 8–12 weeks, though individual timelines vary. Mounjaro is titrated gradually (starting 2.5 mg, increasing weekly), so full effects develop over several months. Patience and consistent lifestyle changes alongside the injection give the best results.
Can I access Mounjaro through the NHS for perimenopause weight gain?
Yes, if you meet eligibility criteria (BMI 30+, or 25–29.9 with weight-related conditions). Refer to your GP and ask for referral to a specialist tier 3 weight management service. Availability and waiting times vary significantly by region and NHS ICB. Private prescription is an alternative route if NHS waiting lists are long in your area.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.